In fact, venture capitalists have increased investment in generative AI by 425% since 2020 to $2.1 billion. In the life sciences industry in particular, leading pharma companies are already ...

Causal AI for predicting clinical efficacy is currently transforming the pharma business model. The gold standard for establishing causality is the prospective, randomized, placebo-controlled ...

In the era of digital health transformation, generative AI (GenAI) has emerged as a breakthrough technology in ...

The rapid progress in AI has also facilitated real-life applications within the pharmaceutical industry that may lead to ...

risk being left at a competitive disadvantage when the AI revolution swings into high gear. “Pharma companies are far behind many industries in terms of digitalization,” says Oliver Hesse ...

The Pharmaceutical Automation and Digitalisation Congress (AUTOMA+) is providing a valuable opportunity to access innovations considering AI implementation in pharmaceutical devices during the ...

In this Q&A, He discussed Boehringer's investments in AI as well as areas where the technology could deliver greater value for pharma.

There’s no denying it; pharma is in its innovation era. The life sciences industry is already undergoing a massive revolution ...

The biotech uses its AI platform to discover the therapeutic potential of plant-based molecules, advancing ten candidates ...

Insilico Medicine(“Insilico”), a global leading generative artificial intelligence (AI)-driven biotechnology company, will be hosting Pharma.AI Week featuring in-depth webinar series from November ...